Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline
Go back to Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline| SPDR S&P INTERNATIONAL INDUSTRIAL SECTOR (NYSE: IPN) | Delayed: 34.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.71 | 52 Week High | $30.88 | |||
| Open | $0.00 | 52 Week Low | $24.64 | |||
| Day High | $34.71 | P/E | N/A | |||
| Day Low | $34.71 | EPS | $0.00 | |||
| Volume | 741,680 | |||||
| Ipsen S.A. Sponsored ADR (AMEX: IPSEY) | Delayed: 44.75 -1.48 (3.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.23 | 52 Week High | $17.79 | |||
| Open | $44.82 | 52 Week Low | $13.01 | |||
| Day High | $44.82 | P/E | N/A | |||
| Day Low | $44.75 | EPS | $0.00 | |||
| Volume | 266 | |||||
